Completado

Outcomes in Education and Counseling for HNPCC Testing

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está evaluando

loss of heterozygosity analysis

+ microsatellite instability analysis

+ mutation analysis

Otro
Quiénes están siendo reclutados

Enfermedades del colon+10

+ Enfermedades del Sistema Digestivo

+ Neoplasias del sistema digestivo

A partir de 18 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Intervencional
Inicio del estudio: febrero de 2000
Ver detalles del protocolo

Resumen

Patrocinador PrincipalNational Human Genome Research Institute (NHGRI)
Última actualización: 24 de octubre de 2014
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de febrero de 2000

Fecha en la que se inscribió al primer participante.

OBJECTIVES: Identify family characteristics, personality traits, and religious and spiritual beliefs that significantly affect individual decisions regarding mutation testing for hereditary nonpolyposis colon cancer (HNPCC) (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues). Determine the impact of negative vs positive mutation test results on family relationships and psychological status. Assess expectations regarding testing and how they influence perceptions of risks and responses to risk notification. Determine the impact of risk notification on the frequency of screening/prevention activities. Formulate a standard diagnostic algorithm for determining microsatellite instability based on the analysis of tumors with this extensive array of markers and correlate specific replication error phenotypes with germline genotype. OUTLINE: Participants complete a baseline assessment of knowledge, risk perception, and personality traits followed by a structured pretest education session. Participants are then offered the choice of whether or not to undergo genetic testing for mutations in hereditary nonpolyposis colon cancer (HNPCC) genes. Participants who choose to undergo genetic testing provide a blood sample for this purpose. Participants who undergo genetic testing receive results and counseling (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues). Available surveillance options are discussed for all participants. Psychological and behavioral outcomes are reassessed at 6 and 12 months for both those choosing and not choosing genetic testing. Tumors (when available) are analyzed for mismatched repair deficiency on the basis of microsatellite instability. PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study, with a specific target of 200 individuals who have not experienced cancer within families identified with hereditary nonpolyposis colon cancer (HNPCC) mutations (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).

NCT00004210NCT00001470
Patrocinador PrincipalNational Human Genome Research Institute (NHGRI)
Última actualización: 24 de octubre de 2014
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 900 pacientes

Número total de participantes que el ensayo clínico espera reclutar.


Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

A partir de 18 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos no permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Enfermedades del colonEnfermedades del Sistema DigestivoNeoplasias del sistema digestivoEnfermedades GastrointestinalesNeoplasias GastrointestinalesEnfermedades IntestinalesNeoplasias IntestinalesNeoplasiasNeoplasias por SitioEnfermedades RectalesNeoplasias del ColonNeoplasias RectalesNeoplasias colorrectales

Criterios

DISEASE CHARACTERISTICS: Meets one of the following criteria: Family history consistent with hereditary nonpolyposis colon cancer (HNPCC)* At least 3 relatives with histologically proven colorectal cancer or HNPCC-associated cancer and 1 is a first-degree relative of the other 2 At least 2 successive generations affected Colorectal cancer (or HNPCC-associated cancer) diagnosed under age 50 in 1 of the relatives Diagnosis of colorectal cancer under age 41 HNPCC-associated cancer/polyps* under age 41 with a microsatellite instability (MSI) phenotype Multiple primary HNPCC-associated cancers* regardless of family history Colorectal or other HNPCC-associated tumor/polyp* demonstrating a positive MSI phenotype and at least 1 second-degree (or closer) and 1 third-degree (or closer) relative with a HNPCC-associated cancer 1 affected family member must have one of the following: Right-sided colon cancer Multiple primary HNPCC-associated cancers Diagnosis of cancer prior to age 51 NOTE: *Recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine: Not specified Radiotherapy: Not specified Surgery: Not specified

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Objetivos del Estudio

Objetivos del Estudio

Objetivos Primarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene 2 ubicaciones

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office

Bethesda, United StatesAbrir Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office en Google Maps

National Human Genome Research Institute

Bethesda, United States
Completado2 Centros de Estudio